Covered recipient · General Payments record
BACHAR DAHMAN
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$971.46
- Reported across 34 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $397.05 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| BOSTON SCIENTIFIC CORPORATION | $141.64 | 1 |
| ABBVIE INC. | $96.55 | 5 |
| Phathom Pharmaceuticals, Inc. | $35.75 | 1 |
| Madrigal Pharmaceuticals | $33.75 | 1 |
| Alnylam Pharmaceuticals Inc. | $25.09 | 1 |
| INTERCEPT PHARMACEUTICALS, INC. | $21.78 | 1 |
| Merck Sharp & Dohme Corporation | $15.21 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $14.14 | 1 |
| Lilly USA, LLC | $13.14 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.78 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103528433 | CMS |
| ABBVIE INC. | $14.98 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103528435 | CMS |
| ABBVIE INC. | $22.06 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103528437 | CMS |
| ABBVIE INC. | $14.79 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103528439 | CMS |
| ABBVIE INC. | $21.94 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103528441 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $14.14 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146990343 | CMS |
| Alnylam Pharmaceuticals Inc. | $25.09 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125855149 | CMS |
| Boston Scientific Corporation | $141.64 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092429945 | CMS |
| Intercept Pharmaceuticals, Inc. | $21.78 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113631162 | CMS |
| Lilly USA, LLC | $13.14 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136060730 | CMS |
| Madrigal Pharmaceuticals | $33.75 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144164077 | CMS |
| Merck Sharp & Dohme LLC | $15.21 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141721238 | CMS |
| Phathom Pharmaceuticals, Inc. | $35.75 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151053111 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.